Objective: To evaluate whether endometriosis could be related to an impaired balance between apoptosis and proliferation, two processes which could be modulated by hormonal status.
In endometriosis, abnormal adhesion of endometrial fragments to ectopic sites could be due to an increase in the adhesive and proliferative properties of menstrual endometrium, a decrease in apoptosis, and/or anomalies in the target tissue microenvironment. The properties of floating endometrial cells that reach the peritoneal cavity are under the influence of the peritoneal fluid, which is known to be proinflammatory in women with endometriosis (7) .
In contrast, the endometrium is regulated by blood factors (8) . In addition, ectopic endometrial cell implantation could be related to modification in apoptosis sensitivity. Indeed, under normal conditions, apoptosis is thought to prevent the dissemination and attachment of differentiated epithelial cells at inappropriate locations when they lose contact with matrix (9-10).
To evaluate the possibility that the balance between proliferation and apoptosis could be impaired and hormonally regulated in endometriosis, we evaluated cell proliferation, steroid hormone receptor levels, and apoptosis on biopsies of human endometrium and endometriosis.
The presence of proliferating cell nuclear antigen (PCNA) (a 36-kd nuclear protein restricted to S phase) and markers of apoptosis (DNA fragmentation, p53, and bcl-2) were assessed by immunohistochemistry in peritoneal endometriosis and in the corresponding endometrium throughout the menstrual cycle and compared with the endometrium from women without endometriosis (11) .
MATERIALS AND METHODS

Antibodies
Monoclonal mouse anti-PCNA, monoclonal mouse anti-human bcl-2 oncoprotein antibody, and anti-p53 protein antibody were from Dako (Glostrup, Denmark), and antihuman estrogen receptor and antihuman P receptor antibodies were from Novocastra (Newcastle, United Kingdom).
Endometrial Samples
The institutional review board of the University of Liege (Belgium) approved the collection and use of human tissue. Normal human endometrium was obtained from nonmeno-pausal fertile women aged 30-45 years undergoing hysterectomy for benign gynecologic indications (subserosal leiomyomata) or laparoscopy for elective tubal ligation and who did not receive any hormonal treatment.
None of these patients had identifiable endometriosis. Endometrial dating was performed according to the method of Noyes et al. (12) . Endometrial samples were obtained throughout the menstrual cycle (five were in the proliferative phase, five in the early secretory phase, and five in the late secretory phase).
Typical endometriotic lesions were removed from the peritoneum of the pouch of Douglas, the broad ligament, or the uterosacral ligament of women aged 26-40 years who were undergoing laparoscopy for pain (10 patients) or infertility (20 patients). Simultaneously, eutopic endometrium was obtained from the same women (10 were in the proliferative phase, 10 in the early secretory phase, and 10 in the late secretory phase).
To distinguish between endometrium from endometriotic and nonendometriotic patients, samples from nonendometri-otic patients were termed normal endometrium, and samples from endometriotic patients were termed eutopic endometrium.
Immunohistochemistry
Endometrium and endometriosis lesions were fixed in neutral buffered 10% formaldehyde for 1 hour. In sections of 5 µm, histologic examination confirmed the presence of ectopic endometrial glands surrounded by stromal cells. Classic immunoperoxidase staining with monoclonal mouse antihuman bcl-2, antihuman p53, antihuman estrogen receptor (ER), and antihuman P receptor (PR) were performed. Protein expression was detected with a streptavidin-biotin peroxidase complex.
Briefly, after blocking endogenous peroxidase activity, sections were microwaved in citrate buffer (pH 6) for antigen retrieval. Slides were then washed in phosphate-buffered saline, incubated in normal swine serum (NSS) for 30 minutes, and then with anti-bcl-2 diluted 1:40 in NSS, anti-p53 diluted 1:25 in NSS for 1 hour at room temperature, anti-PR and anti-ER (overnight at 4°C), and with horseradish perox-idase-conjugated anti-PCNA. Finally, sections were incubated with biotinylated antirabbit and antimouse immunoglobulins and with streptavidin peroxidase (LSAB kit; Dako, Glostrup, Denmark). The reaction was developed with 3-3' diaminobenzidine and hydrogen peroxide.
The slides were counterstained with hematoxylin. Negative controls were performed by replacing the primary antibody with normal serum.
Apoptosis Detection System
Apoptosis was assessed with the principle of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) to detect fragmented DNA in apoptotic cells. Sections were treated according to the manufacturer's recommendations. Briefly, sections were deparaffinized and rehydrated, permeabilized in proteinase K, and treated with terminal deoxynucleotidyl transferase incubation buffer at 37°C for 60 minutes. Sections were then treated with per-oxidase-labeled antidigoxigenin antibody, followed by 3'-3 diaminobenzidine color reaction. Sections were counterstained with hematoxylin.
Quantification
Evaluation of the nuclear staining for TUNEL-positive cells, p53, ER, PR, and PCNA was performed with a computer-assisted cellular imaging system (CAS 200; Bacus Laboratories, Lombard, IL). First, the nuclear threshold of cells was determined to measure the nucleus size. Then, the antibody threshold was assessed to distinguish positive nuclei from negative nuclei. Finally, the software calculated the percentage of positive cells from the total number of cells evaluated. We performed a separate quantification of positive stromal and glandular epithelial cells in endometrium and endometriosis.
This software provided an accurate, objective, and quantitative microscope-based method for the assessment of nuclear staining in tissue sections.
Bcl-2 is a membrane protein, and the staining after immunohistochemistry was distributed around the circumference of cells. We performed a semiquantitative evaluation of the staining in epithelial and stromal cells: the intensity of the staining was scored as 0 = no staining; 1 = weak staining; 2 = moderate staining; and 3 = strong staining.
Statistical Analysis
The Pearson test was used to evaluate the correlation between steroid receptors and apoptosis. The Fisher test was used to analyze the contingency of the results; P<.05 was considered significant.
RESULTS
Cell Proliferation in Normal Endometrium, Eutopic Endometrium, and in Endometriosis
In endometrium, the maximal proliferative activity was found in glandular epithelium in the preovulatory phase. This proliferation rate decreased continuously during the secretory phase until the midluteal phase, for which no more proliferation was detected (P<.0001) (Fig. 1A) . In the stroma, the proliferation index was higher in the proliferative phase than in the early and late secretory phases (P<.0001 between proliferative phase and early secretory phase and P =.0002 between proliferative phase and late secretory phase; data not shown). No significant difference in cell proliferation in eutopic endometrium was seen between endometriotic and nonendometriotic patients.
In endometriotic lesions, the proliferative activity was significantly lower in the proliferative phase of the cycle compared with the endometrium and remained essentially constant throughout the cycle (P=.3 between proliferative phase and early secretory phase and P=.1 between early secretory phase and late secretory phase).
ER and PR in Normal Endometrium, Eutopic Endometrium, and in Endometriosis
In normal and eutopic endometrium, the percentage of ER-and PR-stained nuclei was high in epithelial and stromal cells in the proliferative phase and low in the secretory phase (Fig. 1B and C) .
In endometriotic lesions, hormone receptors did not exhibit the cyclic variation occurring in normal and eutopic endometrium. Estrogen receptor levels were low throughout the cycle in endometriosis (nuclear staining intensity <10%). Progesterone receptor levels were stable throughout the cycle in endometriosis: nuclear staining intensity ranged from 14% ± 5% (mean ± SD) in the proliferative phase to 17% ± 3.5% in the late secretory phase. In normal and eutopic endometrium, the PR levels were 3% ± 0.5% in the late secretory phase (P<.05 compared with endometriosis).
p53, bcl-2, and TUNEL in Normal Endometrium, Eutopic Endometrium, and in Endometriosis
In normal and eutopic endometrium, p53, bcl-2, and TUNEL showed cyclic changes. Deoxyribonucleic acid cleavage was seen at low levels in the proliferative phase, was almost absent in the early secretory phase, and was at a high level in the late secretory phase (Fig. 2) . p53 was essentially detected in the late secretory phase, with marginal differences between the three considered tissues (percentage of positive nuclei: 0 in the proliferative phase for endometrium and endometriosis; 15% ± 1.3% in endometrium; and 7% ± 2.2% in endometriosis in the late secretory phase). Conversely, bcl-2 was highly expressed in the proliferative phase in normal and eutopic endometrium, whereas it was not detected in these tissues during the early and late secretory phases. In endometriosis, the level of DNA fragmentation was very low throughout the menstrual cycle. Although bcl-2 was found regardless of the cycle phase, its levels were high in the proliferative and late secretory phases and low in the early secretory phase.
In endometrium (normal and eutopic), there was a positive correlation between proliferation and ER levels (P<.000l and r = 0.9448 for proliferative phase) and an inverse correlation between proliferation ER levels and ap-optosis (P<.000l and r = -0.8660 for the proliferative phase and P<.0001 and r = -0.8852 for the late secretory phase). Proliferation and ER levels were low during the late secretory phase, whereas apoptosis was high. No significant correlation was found between proliferation ER, PR, and DNA cleavage of glandular and stromal endometriotic cells (P>.05 and squared = 40.50%).
DISCUSSION
Although retrograde menstruation is a common phenomenon in women, it does not result in endometriosis in all women. This suggests that retrograde menstruation might promote endometrial tissue dissemination in the peritoneal cavity but that some other factors are required for the implantation and growth of ectopic endometrium. These additional factors could be an impaired peritoneal environment (cytokines, chemokines, Inflammatory cells) or alteration of the peritoneal lining or specific features of the endometrium itself (13).
It is likely that in healthy women, endometrial cells and tissue fragments expelled during menses do not survive in ectopic locations because of programmed cell death. Indeed, in normal tissue, epithelial cells require interactions with the extracellular matrix to survive and grow. Disruption of cell-matrix interactions induce cell death through a process called αnoikis (10) . This might prevent detached normal cells from implanting in a new and inappropriate location. A decrease in apoptosis might lead to ectopic survival and implantation of endometriotic cells and development of endometriosis.
Different studies have been performed to evaluate apoptosis in endometriosis and endometrium. Apoptotic cells were detected with an ELISA-based cell death detection kit (14) or the TUNEL assay for DNA fragmentation (15) . To evaluate cell death repressor activity, bcl-2 was also determined by immunohistochemistry (16) (17) (18) (19) (20) . To the best of our knowledge, no study has yet evaluated the proliferation rate and steroid hormone receptor levels in parallel with apoptosis assessment. Proliferative properties have been determined in combination with apoptosis in adenomyosis but not in endometriosis (21) .
The present study combined for the first time an evaluation of markers of apoptosis, proliferation, and steroid hormone receptors in endometrial and endometriotic cells.
The main interesting finding was a lower sensitivity of endometriotic cells to apoptosis. Controversial data regarding the apoptotic index in endometriosis vs. endometrium have been reported: bcl-2 was negative in almost all samples from ovarian endometriosis (18, 20) , but bcl-2 was significantly increased in another study (16) ; apoptosis was increased in ovarian endometriosis (20) but decreased in single-cell suspensions of ectopic endometrium (14) .
The comparison of results obtained in different studies is hampered by the use of different methodologies and different endometriotic lesions (ovarian vs. peritoneal endometriosis). Ovarian and peritoneal endometrioses are thought to have different pathogenetic origins. Ovarian endometriotic cysts could arise from invagination and metaplasia of ovarian epithelium lining, and peritoneal endometriosis is thought to be the consequence of implantation of shed endometrium (22) .
Therefore, ovarian endometriosis could have different biological features. In ovarian endometriosis and not in peritoneal endometriosis, apoptosis was greater compared with eutopic endometrium (18, 20) . Some studies compared the apoptotic level in endometriosis with that in endometrium from the same patients; other studies also considered the levels of apoptosis in endometrium from normal fertile women. In these studies, as in our study, apoptosis was impaired in endometriosis, and no cyclic change was demonstrated (14, 16, 17) .
Finally, some authors used endometrium from infertile patients without endometriosis as a control. However, endometrium from infertile women can not be used as a control because such endometrium can be considered abnormal in terms of cell adhesion receptors (23, 24) and microscopic peritoneal endometriosis (26, 27) . Therefore, endometrium from infertile women could not be used as a control for comparison with endometrium from endometriotic patients.
To overcome these problems, we analyzed both apoptotic and proliferative parameters in endometrium from normal fertile patients (control endometrium) and in endometriotic patients (eutopic endometrium).
No difference was demonstrated between endometrium from endometriotic vs. nonendometriotic women. This is consistent with the report of Jones et al. (16) , in which no significant differences in apoptotic cell rate were found in endometrium from endometriotic and nonendometriotic women. In contrast, a decreased susceptibility to spontaneous apoptosis of endometrial tissue from endometriotic patients was described when compared with fertile control subjects (14) .
In this study, apoptosis was evaluated in single endometrial cell suspensions after enzymatic digestion. However, it should be noted that the properties of monodispersed cells could be different from those of tissues in which paracrine interactions occur between epithelial and stromal cells or between endometriotic cells and the peritoneal micro-environment.
Other experiments also reported decreased apoptosis in eutopic endometrium from women with endometriosis compared with endometrium from control women (38) . Although these investigators suggested a regulation of apoptosis and bcl-2 by ovarian steroids, ER and PR were not evaluated. In our study, although no difference in apoptosis was detected between endometrium from normal patients and endometrium from patients with endometriosis, the most interesting finding is the reduction of apoptosis in endometriotic lesions.
Steroid receptors were evaluated in parallel with apoptotic markers, and no correlation was found between the level of ovarian receptors and apoptosis in endometriosis. Apoptosis was not correlated with phases of the menstrual cycle in endometriosis, as in endometrium. Clinical studies (28) have suggested that in women with endometriosis, misplaced endometrial cells implanted in ectopic locations can lead to endometriotic lesions, whereas in healthy women such implantation does not succeed.
Our study indicates that because there was no difference in spontaneous apoptosis between endometrium from endometriotic and nonendometriotic patients, ectopic implantation of endometrium could not be ascribed to a decrease in apoptosis in endometrium. These results are in agreement with in vitro and animal studies using endometrium from women without endometriosis in their model of ectopic implantation and showing peritoneal adhesion of such normal endometrium (29) (30) (31) (32) . Normal endometrium from patients without endometriosis had, therefore, the ability to implant at ectopic locations.
Endometriotic lesions showed an increase in bcl-2 expression compared with endometrium. Such an elevated bcl-2 expression could promote the survival of endometriotic tissue at ectopic sites. These results are consistent with previous reports (16) . Endometriotic cells, like tumor cells, could gain growth advantage by blocking the apoptotic pathway and stimulating cell proliferation.
Endometriotic cells, however, showed no enhanced proliferative properties, unlike tumor cells, which develop uncontrolled proliferation (33) . Endometriosis could not be considered a mere graft of endometrial tissue with the same phenotypic characteristics: endometrium implanted at ectopic locations exists under different biologic properties than endometrium at eutopic locations. The transformation of the ectopic tissue could be the consequence of local factors in the peritoneal environment.
In agreement with other studies, no difference of proliferation rate was seen in endometrium from patients with vs. without endometriosis (34) . Interestingly, significantly reduced proliferation activity was observed in endometriosis compared with endometrium. That could relate to the lower ER status of these cells.
Regarding steroid hormone receptor levels, no difference was demonstrated in endometrium from endometriotic vs. nonendometriotic women, and the levels remained low in endometriotic lesions without significant cyclic modulation. Endometriotic cells seem to be partially independent of hormonal regulation. This could explain why hormonal treatment is unable to eradicate endometriotic lesions.
The specific relationship between steroid hormones, apoptosis, and the development and maintenance of endometriosis remains unclear. It is well known that endometriotic cells respond to cyclic estrogen and P stimulation in an incomplete and variable fashion compared with endometrium. This could be due to differences in vascularity and the degree of surrounding fibrosis near the stroma. The absence of cyclic modulation of ER and PR in endometriotic lesions in our study was in agreement with previous observations.
There is no consensus concerning the levels of ER and PR expression in endometriosis, which were variable in different studies, either higher than in endometrium (35) (36) or lower (37) (38) . The differences between the studies could be explained by the site of endometriotic biopsy (ovarian vs. peritoneal) or by the assay methods used.
In conclusion, for the first time, apoptosis, steroid hormone receptors, and cellular proliferation were evaluated simultaneously in endometrium from normal fertile patients (normal endometrium) and from patients with endometriosis (eutopic endometrium) and in peritoneal endometriosis. The induction of apoptosis seemed to be regulated by hormonal changes in the endometrium (normal and eutopic) and had an inverse correlation with the presence of bcl-2, as determined by immunohistochemistry. Endometrium from normal fertile patients and from endometriotic patients displayed similar pattern of parameters evaluated.
Conversely, the peritoneal endometriosis did not present cyclic variation in proliferation, steroid hormone receptor levels, and apoptotic markers (TUNEL, bcl-2) and thus had features different from those observed in the endometrium (normal and eutopic). Endometriotic cells are less sensitive to apoptosis. Altogether, these findings suggest that the success of ectopic implantation is unrelated to an excess of proliferation but rather is likely to be promoted by a decreased susceptibility to apoptosis.
